Cargando…
GSOR10 Presentation Time: 3:15 PM: Single Implant Hybrid Interstitial Brachytherapy for Cervical Cancer during the COVID-19 Pandemic: An Institutional Approach
Autores principales: | Damast, Shari, Tien, Christopher J., Young, Melissa R., Altwerger, Gary, Ratner, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215885/ http://dx.doi.org/10.1016/j.brachy.2021.06.086 |
Ejemplares similares
-
Single application hybrid interstitial brachytherapy for cervical cancer: an institutional approach during the COVID-19 pandemic
por: Damast, Shari, et al.
Publicado: (2022) -
Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer
por: Qian, Jack M., et al.
Publicado: (2017) -
Treatment of early stage vaginal cancer with EBRT and MRI-based intracavitary brachytherapy: A retrospective case review
por: Damast, Shari, et al.
Publicado: (2016) -
A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience
por: Murakami, Naoya, et al.
Publicado: (2019) -
High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma
por: Damast, Shari, et al.
Publicado: (2015)